Head and neck cancer is the 6th most common cancer worldwide, accounting for 5 to 6% of all cancer cases. Surgical resection and/or radiotherapy have long been regarded as the standard treatment, while chemotherapy can be added as an adjunct. However, conventional chemotherapy has certain drawbacks like nonspecific distribution, short circulation time, and tumor resistance. Recently, targeted therapeutics with nanoparticles have emerged as promising alternatives to overcome these drawbacks of conventional approaches and among the diverse classes of nanomaterials, carbon nanotubes (CNTs), due to their unique physicochemical properties, have become a popular tool in cancer diagnosis and therapy. Carbon nanotubes are tubular materials with nanometer-sized diameters and axial symmetry, with unique properties, such as ease of cellular uptake, high drug loading, and thermal ablation, which render them useful for cancer therapy. The important biomedical applications of CNTs include their contribution in the field of drug delivery, thermal therapy, photodynamic therapy, gene delivery, biological detection, and imaging. More recently, they have also been used as vehicles for antigen delivery, a novel immunization strategy against infectious diseases and cancer. These multifunctional and multiplex nanoparticles are now being actively investigated and are on the horizon as the next generation of nanoparticles, facilitating personalized and tailored cancer treatment. However, concerns over certain issues, such as biocompatibility and toxicity have been raised and warrant extensive research in this field.
INTRODUCTION
Cancer is one of the leading causes of death worldwide. According to the World Cancer Report 2012 issued by the World Health Organization, there were an estimated 14.1 million new cases of cancer worldwide in 2012 and 8.2 million deaths from the disease. 1 Early radical resection of the tumor is the most desirable treatment, but only a few cases are diagnosed at an early stage. However, for most patients local invasion and distant metastasis are present at the time of diagnosis. For those unoperable patients and those who received palliative operation, chemotherapy and radiotherapy are the mainstay. Since chemotherapeutic drugs affect all rapidly dividing cells, including the healthy cells, they can cause several undesirable effects in the patient's body. Therefore, the challenge is to develop new methods for early detection of cancer and targeted delivery of drugs to the cancerous cells only. Recently, targeted therapeutics with nanoparticles have gained prominence in the biomedical field, [2] [3] [4] and among these diverse classes of nanomaterials, carbon nanotubes (CNTs) have attracted particular attention due to their unique physicochemical properties. Since past 18 years, different CNT preparations have been reported to be used in drug delivery, cellular therapy, and more recently in molecular imaging and as sensors for cancer biomarker detection in serum.
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CARBON NANOTUBeS: STRUCTURe AND PROPeRTIeS
Carbon nanotubes, first discovered by Iijima in 1991, 8 can be imagined as the cylindrical roll-up of one or more graphene sheets containing only sp 2 hybridized carbon atoms in a honeycomb arrangement. 9 Both ends of the tubes are capped by a hemispherical arrangement of carbon networks called fullerenes, formed by warping of the graphene sheet. Structurally, CNTs are of two types: single-walled carbon nanotubes (SWCNTs), which consist of one layer of cylinder graphene, and multi-walled (MWCNTs) carbon nanotubes, which contain several concentric graphene sheets. The length of the nanotubes ranges from several hundred nanometers to several millimeters, but their diameters depend on their class, diameter of MWCNT being greater than that of SWCNT. Carbon nanotubes possess remarkable properties, such as high aspect ratio, ultra-light weight, tremendous strength, high thermal conductivity, and significant electronic properties ranging from metallic to semiconducting. However, in the field of cancer diagnostic and therapeutic, three main attributes of CNTs have been exploited:
• Being small in size, they can pass through the leaky vasculature within the tumor or can transport deoxyribonucleic acid (DNA).
• High surface area to volume ratio provides a good platform for their ability to efficiently transport different chemicals.
• Their ability to contain chemicals.
Although in recent years a variety of different nanocarriers have been evaluated, CNTs have potential advantages over the others. The advantages include:
• Ability to carry a high cargo loading, intrinsic stability, and structural flexibility, which will lead to increased circulation time, resulting in better bioavailability of the drug molecules carried.
• Ability to enter the mammalian cells.
• Requirement of lesser quantity of the drug for the desired effect.
• No requirement of solvent for drug delivery, thereby preventing undesired health effects from the solvent.
• No risk of the protective nanocarrier degrading.
• A range of drugs can be attached for therapeutic and diagnostic purposes. 
Applications in Cancer Diagnosis
Molecular Imaging with SWCNTs
Since radical resection of the tumor at its early stage is the treatment of choice, early screening and detection are of immense importance. Most cancers are asymptomatic during their early stage. Since the conventional clinical cancer imaging techniques, such as film radiography, computed tomography (CT), magnetic resonance imaging (MRI), and diagnostic ultrasonography (USG), require a macroscopic anatomic change for information to be recorded by an image receptor, they can easily avoid being detected by these imaging techniques. On the other hand, radionuclide imaging, such as positron emission tomography, though identifies early-stage alterations in molecular biology, is not specific for malignant diseases but for increased metabolism. [11] [12] [13] Hence, it is imperative to develop new aids for early cancer diagnosis. Hong et al first reviewed molecular imaging with SWCNTs. Carbon nanotubes can act as a contrast medium in different imaging modalities, such as magnetic resonance, near-infrared fluorescence, Raman spectroscopy, photoacoustic tomography, and radionuclide-based imaging, where gadoliniumfunctionalized ultra-short SWCNT (gadonanotube) improved resolution, sensitivity, and tissue penetration as compared with the traditional contrast agents. 14 
Cancer Biomarker Detection
Cancer cells often overexpress characteristic protein biomarkers, which provide an opportunity for early diagnosis of the disease. Carbon nanotube exhibiting unique electronic, mechanical, and thermal properties has been proposed as a promising tool for detecting the expression of indicative biological molecules at early stage of cancer with high sensitivity, selectivity, rapidity, and low detection limit. Yu et al in 2006 reported a combination of electrochemical immunosensors using SWCNT forest platform with multilabel secondary antibody-nanotube biconjugates for highly sensitive detection of a cancer biomarker in serum and tissue lysates. Although further research is required in this field, it is believed that CNT-based detecting measurement may serve as an alternative method for cancer biomarker diagnosis in clinical analysis in the future.
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Applications in Cancer Therapy
Drug Delivery by CNTs
Chemotherapy is generally used alongside surgery and/ or radiotherapy in advanced cancer cases. The most common chemotherapeutic agents used are platinumbased drugs (cisplatin or carboplatin) and combinations with taxanes (e.g., docetaxel) or 5-fluorouracil. Clinical studies revealed that approximately 30% of patients with advanced head and neck squamous cell carcinoma responded to a single agent, such as cisplatin or 5-fluorouracil, but no improvement in overall survival was observed. 16 A combination of chemotherapeutic agents did improve the drug response but had no effect on overall survival. 17 The conventional delivery methods of chemotherapeutic agents have several limitations:
• First, some drugs have poor solubility and low bioavailability and contain toxic solvents in their formulation.
• Second, they have a short circulation time because of their physiological instability, degradation, and clearance.
• Third, the nonspecific distribution of the drugs limits the concentration achieved in the tumor, and causes harmful side effects because of their unwanted accumulation in healthy tissues. 16 Therefore, advanced drug delivery systems (DDS), based on nanotechnology and a tumor-targeted strategy, hold considerable potential to enhance chemotherapeutic efficacy. Researchers have found that functionalized CNTs with the help of specific peptides or ligands on their surface to recognize cancer-specific receptors on the cell surface, can carry therapeutic drugs more safely and effectively into the cells that were previously unreachable, which makes them ideal candidates for drug delivery. 5 These delivery systems generally consist of three parts:
• Functionalization of CNTs • Anticancer drug loading • Drug targeting Functionalization of CNTs: Functionalization is a process of attachment of appropriate molecules to the CNT surface to evade the host defenses and to make them more biocompatible and less toxic. Carbon nanotube tips have a higher affinity for binding functional groups than the sidewalls. 18 Functionalization can be done noncovalently or covalently. Noncovalent functionalization involves van der Waals interactions, π-π interactions, and hydrophobic interactions of biocompatible groups with the surface of CNT. This method preserves the aromatic structure and electronic characteristics of CNTs, but the bonding being weak it is not suitable for targeted drug delivery applications. Covalent functionalization involves oxidation of CNTs with strong acid, which attaches COOH group to the sidewall of CNTs rendering them water soluble and biocompatible. Biocompatibility may be enhanced by further coating with polyethylene glycol (PEG), which is a hydrophilic substance. Thus, this method is suitable for use as a DDS.
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Anti-cancer drug loading: The location of the drug to be delivered by the CNT can be internal or external. Internalization relies on van der Waals force for insertion into the CNT and is the best method for the drugs that are sensitive to external environment and easily broken. In this process, CNT caps are first opened by electric current or with acid. The most common mechanism for filling CNTs is by capillarity. Drugs can attach to the CNT via the functional group either by covalent bonding where a linker with which both the drug and CNT react to form covalent bond is used or by noncovalent bonding, which involves physical conjugation of the anticancer drug to CNT via hydrophobic interaction, π-π stacking, or electrostatic adsorption. Then, the CNTs are washed with a solution, i.e., less soluble for the impregnating fluid and can dissolve only the deposits left outside CNT. Finally, CNTs are capped by passing a current that fuses the ends closed. 10 Drug targeting: Accumulation at a targeted location is important in DDS. Targeted nanoscale drug deliveries are of two types: passive targeting and active targeting.
In passive targeting, PEGylated conjugates are delivered to the tumor tissue in increased amount due to the effect of enhanced permeability and retention (EPR). Due to angiogenesis, the new blood vessels that are formed are leaky, promoting increased permeability of nanoparticles. Poor lymphatic drainage in tumor also causes retention of nanoparticles. This combined effect is called EPR.
Active targeting uses antibody-or ligand-targeted binding as a means of selective delivery to cancer cell or tumor. 10 After targeted delivery, anticancer drug will be released in cancer cell by different techniques:
• Extracellular tumor tissue and intracellular lysosomes and endosomes are acidic and may help in release of anticancer drug at low pH.
• Heat in acidic environment may help in release of drug.
• Cleavage of disulfide bond by thiol-reducing enzyme may help in release of drug.
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Carbon Nanotubes in Lymphatic Targeting
Lymphatic metastasis is common in cancers and often contributes to tumor recurrence, even after extended lymph node dissection. carbon nanotubes can be used to effectively block the metastasis of cancers through the lymphatic system. A lymphatic targeted DDS has been developed using magnetic multiwalled carbon nanotubes (mMWCNTs), which successfully delivered anticancer drug to lymph nodes with high efficiency under the guidance of a magnetic field. [22] [23] [24] In another approach, poly(acrylic acid)-grafted MWCNTs have been tried, which were seen only in the local lymphatic nodes sparing the major organs, after 3 hours of subcutaneous injection, suggesting that they may have the potential to be used as a vital staining dye and simplify lymph node identification during surgery even when they are very small. 25, 26 Thus, without the help of such nanostructures, anticancer drugs cannot preferentially distribute in the lymphatic system.
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Thermal Therapy Applications
There has been much interest in the use of CNTs in conjunction with radiofrequency and laser therapy in cancer treatment. Thermal ablation above 55°C has shown coagulative necrosis and protein denaturation of the malignant cells and also the permeability of the tumor vasculature is increased due to the local rise in temperature. The transmission of laser beams could be divided into two different types: short laser nanosecond exposure and long laser exposure. Nanosecond exposure is usually used for the ablation of metastatic or individual tumor cells. Although temperatures using this method can reach a maximum of 300°C, its nanosecond exposure ensures minimal damage to surrounding tissues. The second method requires a few minutes of laser exposure and is generally used for ablation of primary cancer cells that are relatively large in size. The latter usually disables cell function by thermal protein denaturation and, unlike short laser exposure, may affect healthy cells as well as cancer cells. The temperature range for this type of laser is typically 45 to 65°C. Also, laser, being a single point source of thermal energy, results in uneven tumor heating, or production of tumor seeding along the needle track that can result in tumor recurrence. Carbon nanotube-mediated thermal ablation has potential advantages over the conventional ones. The advantages include:
• Targeting of malignant tumor site specifically and selectively ablating the tumor cells • Prevention of uneven tumor heating • Prevention of tumor seeding • Production of temperature gradients that extend more deeply into the tissue • Ability to carry magnetic nanoparticles, which can be localized in deep tissue, fixed at a specific position by an external magnetic field and then alteration of the alternating current field can be used to change the temperature of the magnetic nanoparticles. Here, CNT acts as a shell, protecting the biological environment against oxidation and toxicity of the magnetic nanoparticles.
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Carbon Nanotube-mediated Photodynamic Therapy
The use of CNTs as a new photosensitizer for photodynamic therapy (PDT) is another area of research currently under investigation. Photodynamic therapy is a confined therapy capable of efficiently destroying tumors while at the same time sensitizing the immune system to seek out and destroy metastases. Hence, it could be a better alternative for cancer therapy in comparison to the conventional treatments like surgery, radiation therapy, and chemotherapy, which tend to be immunosuppressive. 33 Singlet oxygen generated during PDT can react rapidly with cellular molecules and mediate cellular toxicity to cause cell damage, ultimately leading to cell death. However, the lifetime and diffusion distance of singlet oxygen are very limited. To overcome this drawback, CNT-based PDT with a novel molecular complex of a photosensitizer consisting of an single-stranded DNA aptamer and SWCNTs has been developed by Zhu et al, 34 which can control and regulate singlet oxygen generation. However, presently the knowledge of CNTbased PDT is limited and further research is needed in this area.
Delivery of Therapeutic Gene by CNTs
Gene therapy involving transport of the correct gene by viral or nonviral vectors to the affected area is the most promising method in cancer treatment and is expected to be an alternative method to traditional chemotherapy. Although viral gene delivery achieves a high level of gene expression, the currently used viral vectors are immunogenic and have limited packaging capacity. These limitations have made nonviral vectors an attractive alternative to viral vectors. However, the nonviral vectors have lower efficiency of gene expression due to poor pharmacokinetic profile. Carbon nanotubes seem to represent a very good nonviral vector for gene therapy because of low immunogenicity, good membrane penetration, higher level of gene expression compared with the naked DNA alone and ability to transfer DNA without degradation. [35] [36] [37] [38] [39] [40] Thus, it is believed that CNTbased gene transfer vector systems will play a great role in the treatment of cancer in the future.
CARBON NANOTUBeS: TOXICITY
Although there are exciting prospects for the application of CNTs in medicine, concerns over adverse and unanticipated effects on human health have also been raised.
• Carbon nanotubes may exert dose-dependent cytotoxicity, a high dose of nanoparticles having major impact on toxicity.
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• Toxicity may be relevant to the route of administration, the subcutaneous route of administration being the least toxic.
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• Carbon nanotubes seem to possess fibrous characteristics having high length-to-diameter (aspect) ratio resulting in low solubility. 42, 43 • Carbon nanotubes have been found to be associated with defective phagocytosis, leading to chronic inflammation. 44 • Low clearance rate of CNTs could lead to the formation of granulomas.
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CONCLUSION
The introduction of nanotechnology in biological systems has led to the beginning of a new chapter in the field of research. The novel properties of carbon nanotubes allow them to be multifunctional therapeutic agents in cancer treatment. However, a detailed understanding of the pharmacological and toxicological properties of CNTs and a balanced evaluation of risk/benefit ratio are required before they can be implemented for routine clinical use.
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